In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging

Cancer Immunology, Immunotherapy

Volumn 61, Issue 3, 2012, Pages 363-371

  Provinciali, Mauro ^a   Barucca, Alessandra ^a   Pierpaoli, Elisa ^a   Orlando, Fiorenza ^a   Pierpaoli, Sara ^a   Smorlesi, Arianna ^a  

^a INRCA   (Italy)

Author keywords

Aging; DNA vaccination; Electroporation; HER 2 neu

Indexed keywords

DNA VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; CANCER VACCINE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNIZATION; CANCER PREVENTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFICACY; ELECTROPORATION; GENE EXPRESSION; HUMORAL IMMUNITY; IN VIVO GENE TRANSFER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; TUMOR; TUMOR CELL; TUMOR IMMUNITY; ANIMAL; BAGG ALBINO MOUSE; CYTOTOXICITY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; METHODOLOGY; PLASMID; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TIME; TRANSGENIC MOUSE; TREATMENT OUTCOME; TUMOR CELL LINE; VACCINATION;

AGING; ANIMALS; CANCER VACCINES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; ELECTROPORATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INJECTIONS, INTRAMUSCULAR; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PLASMIDS; RATS; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME; VACCINATION; VACCINES, DNA;

EID: 84860798996     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1107-2     Document Type: Article

References (27)

1. Finn OJ, Forni G (2002) Prophylactic cancer vaccines. Curr Opin Immunol 14:172-177 (Pubitemid 34188475)
2. Quaglino E, Rovero S, Cavallo F, Musiani P, Amici A, Nicoletti G et al (2002) Immunological prevention of spontaneous tumors: a new prospect? Immunol Lett 80:75-79 (Pubitemid 34025080)
3. Cavallo F, Forni G (2009) Recent advances in cancer immunotherapy with an emphasis on vaccines. Exp Rev Vaccines 8:25-28
4. Colombo MP, Forni G (1994) Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol Today 15:48-51
5. Cavallo F, Signorelli P, Giovarelli M, Musiani P, Modesti A, Brunda MJ et al (1997) Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. J Natl Cancer Inst 89:1049-1058 (Pubitemid 27327870)
6. Provinciali M, Smorlesi A (2005) Immunoprevention and immunotherapy of cancer in aging. Cancer Immunol Immunother 54:93-106
7. Gravekamp C (2007) Cancer vaccines in old age. Exp Gerontol 42:441-450
8. Provinciali M, Smorlesi A, Donnini A, Bartozzi B, Amici A (2003) Low effectiveness of DNA vaccination against HER-2/ neu in ageing. Vaccine 21:843-848 (Pubitemid 36126417)
9. Quaglino E, Iezzi M, Mastini C, Amici A, Pericle F, Di Carlo E et al (2004) Electroporated DNA vaccine clears away multifocal mammary carcinomas in Her-2/neu transgenic mice. Cancer Res 64:2858-2863
10. Smorlesi A, Papalini F, Amici A, Orlando F, Pierpaoli S, Mancini C et al (2006) Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma. Vaccine 24:1766-1775 (Pubitemid 43238257)
11. Rivnay B, Globerson A, Shinitzky M (1979) Viscosity of lymphocyte plasma membrane in aging mice and its possible relation to serum cholesterol. Mech Ageing Dev 101:71-79 (Pubitemid 9129384)
12. Rivnay B, Bergman S, Shinitzky M, Globerson A (1980) Correlation between membrane viscosity, serum cholesterol, lymphocyte activation and aging in man. Mech Ageing Dev 12:119-126 (Pubitemid 10113065)
13. 51CR release assay. J Immunol Meth 155:19-24
14. Bryant J, Day R, Whiteside T, Herberman RB (1992) Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Methods 146:91-96
15. Barber DL, Wherry EJ, Ahmed R (2003) Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol 171:27-31 (Pubitemid 36745269)
16. Giovarelli M, Musiani P, Modesti A, Dellabona P, Casorati G, Allione A et al (1995) Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J Immunol 155:3112-3123
17. Rovero S, Amici A, Di Carlo E, Bei R, Nanni P, Quaglino E et al (2000) DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice. J Immunol 165:5133-5142
18. Amici A, Smorlesi A, Noce G, Santoni G, Cappelletti P, Capparuccia L et al (2000) DNA vaccination with full-length or truncated neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Gene Ther 7:703-706 (Pubitemid 30255775)
19. George AJT, Ritter MA (1996) Thymic involution with ageing: obsolescence or good housekeeping? Immunol. Today 17:267-272 (Pubitemid 26183490)
20. Fabris N, Mocchegiani E, Provinciali M (1997) Plasticity of neuro-endocrine-thymus interactions during ageing. Exp Gerontol 32:415-430
21. Pawelec G, Solana R (1997) Immunosenescence. Immunol Today 18:514-516 (Pubitemid 27488097)
22. Provinciali M (2009) Immunosenescence and cancer vaccines. Cancer Immunol Immunother 58:1959-1967
23. Provinciali M, Argentati K, Tibaldi A (2000) Efficacy of cancer gene therapy in ageing: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice. Gene Ther 7:624-632 (Pubitemid 30175567)
24. Lustgarten J, Dominguez A, Thoman M (2004) Aged mice develop protective antitumor immune responses with appropriate costimulation. J Immunol 173:4510-4515 (Pubitemid 39280681)
25. Chapman HA Jr, Hibbs JB Jr (1977) Modulation of macrophage tumoricidal capability by components of normal serum: a central role for lipid. Science 197:282-295
26. Provinciali M, Fabris N, Pieri C (1990) Improvement of Natural Killer cell activity by in vitro active lipids (AL721) administration in old mice. Mech Ageing Dev 52:245-254 (Pubitemid 20101960)
27. Sharma S, Dominguez A, Lustgarten J (2006) Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp Gerontol 41:78-84 (Pubitemid 43031371)